Home

Intelligence

Services

Subscriptions

News

About Us

Sign In

 

Document Preview

Agreement and Plan of Merger

 

Click "Add to Cart" button to purchase document. 
Documents are emailed immediately after purchase. 
You can also browse documents by
title, category, or company... or click here for help finding documents.

 

Title:

Agreement and Plan of Merger

Entities:

Clinical Data, Inc.

Date:

2005

Size:

263KB total

Price:

$76

ID:

#1115139

 

 

► Plans ► Agreements ► Agreements & Plans of Merger
► Technology ► Scientific & Technical Instruments

 

 

Start of Preview


Exhibit 99.1

 

AGREEMENT AND PLAN OF MERGER

 

by and among

 

CLINICAL DATA, INC.,

 

SAFARI ACQUISITION CORPORATION

 

and

 

GENAISSANCE PHARMACEUTICALS, INC.

 

Dated as of June 20, 2005

 



 

TABLE OF CONTENTS

 

ARTICLE I

THE MERGER

 

 

 

 

1.1

Effective Time of the Merger

 

 

 

 

1.2

Closing

 

 

 

 

1.3

Amendment of Company Charter

 

 

 

 

1.4

Amendment of Parent Charter

 

 

 

 

1.5

Effects of the Merger

 

 

 

 

ARTICLE II

CONVERSION OF SECURITIES

 

 

 

 

2.1

Conversion of Capital Stock

 

 

 

 

2.2

Exchange of Certificates

 

 

 

 

ARTICLE III

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

 

 

 

 

3.1

Organization, Standing and Power; Subsidiaries

 

 

 

 

3.2

Capitalization

 

 

 

 

3.3

Authority; No Conflict; Required Filings and Consents

 

 

 

 

3.4

SEC Filings; Financial Statements; Information Provided

 

 

 

 

3.5

No Undisclosed Liabilities; Indebtedness

 

 

 

 

3.6

Absence of Certain Changes or Events

 

 

 

 

3.7

Taxes

 

 

 

 

3.8

Owned and Leased Real Properties

 

 

 

 

3.9

Intellectual Property

 

 

 

 

3.10

Agreements, Contracts and Commitments; Government Contracts

 

 

 

 

3.11

Litigation; Product Liability

 

 

 

 

3.12

Environmental Matters

 

 

 

 

3.13

Employee Benefit Plans

 

 

 

 

3.14

Compliance With Laws

 

 

 

 

3.15

Permits

 

 

 

 

3.16

Labor Matters

 

 

 

 

3.17

Insurance

 

 

 

 

3.18

Assets

 

 

 

 

3.19

Customers and Suppliers

 

 

 

 

3.20

Opinion of Financial Advisor

 

 

 

 

3.21

Section 203 of the DGCL Not Applicable

 

 

i



 

3.22

Brokers; Schedule of Fees and Expenses

 

 

 

 

ARTICLE IV

REPRESENTATIONS AND WARRANTIES OF THE PARENT AND THE TRANSITORY SUBSIDIARY

 

 

 

 

4.1

Organization, Standing and Power

 

 

 

 

4.2

Capitalization

 

 

 

 

4.3

Authority; No Conflict; Required Filings and Consents

 

 

 

 

4.4

SEC Filings; Financial Statements; Information Provided

 

 

 

 

4.5

Absence of Certain Changes or Events

 

 

 

 

4.6

Intellectual Property

 

 

 

 

4.7

Agreements, Contracts and Commitments

 

 

 

 

4.8

Litigation; Product Liability

 

 

 

 

4.9

Compliance With Laws

 

 

 

 

4.10

Permits

 

 

 

 

4.11

Operations of the Transitory Subsidiary

 

 

 

 

4.12

Opinion of Financial Advisor

 

 

 

 

4.13

Brokers; Schedule of Fees and Expenses

 

 

 

 

ARTICLE V

CONDUCT OF BUSINESS

 

 

 

 

5.1

Covenants of the Company

 

 

 

 

5.2

Confidentiality

 

 

 

 

ARTICLE VI

ADDITIONAL AGREEMENTS

 

 

 

 

6.1

No Solicitation

 

 

 

 

6.2

Joint Proxy Statement/Prospectus; Registration Statement

 

 

 

 

6.3

Nasdaq Quotation

 

 

 

 

6.4

Access to Information

 

 

 

 

6.5

Stockholders Meetings

 

 

 

 

6.6

Legal Conditions to the Merger

 

 

 

 

6.7

Public Disclosure

 

 

 

 

6.8

Section 368(a) Reorganization

 

 

 

 

6.9

Affiliate Legends

 

 

 

 

6.10

Nasdaq Stock Market Listing

 

 

 

 

6.11

Company Stock Plans and Company Warrants

 

 

 

 

6.12

Indemnification

 

 

 

 

6.13

Notification of Certain Matters

 

 

ii



 

6.14

Exemption from Liability Under Section 16(b)

 

 

 

 

ARTICLE VII

CONDITIONS TO MERGER

 

 

 

 

7.1

Conditions to Each Party’s Obligation To Effect the Merger

 

 

 

 

7.2

Additional Conditions to Obligations of the Parent and the Transitory Subsidiary

 

 

 

 

7.3

Additional Conditions to Obligations of the Company

 

 

 

 

ARTICLE VIII

TERMINATION AND AMENDMENT

 

 

 

 

8.1

Termination

 

 

 

 

8.2

Effect of Termination

 

 

 

 

8.3

Fees and Expenses

 

 

 

 

8.4

Amendment

 

 

 

 

8.5

Extension; Waiver

 

 

 

 

ARTICLE IX

MISCELLANEOUS

 

 

 

 

9.1

Nonsurvival of Representations and Warranties

 

 

 

 

9.2

Notices

 

 

 

 

9.3

Entire Agreement